The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
that word is coming out as ***** - re t@rd...in that case i apologise for calling you a hypocrite
bit of give n take
what i found annoying was that you presumably called me a ******, even though you blanked out my name.
unlike that fkin hypocrite who was calling 20-30p a few days ago
hhaeheho - you are one f**king hypocrite
depends what your entry price was. No chance 20% from these levels on SA new strain.
esp. if there are NDAs on the US sales
yesterday? have i missed something?
*again
Something has clearly gone wrong on the India side.
One thing that concerned me a few months back (which was part of the reason that made me sell out in the first period of holding) was the whole issue with the company refusing to tell investors the date that they originally applied for FDA approval, and instead their standard response to investors was why does it matter! That same attitude is now coming to the fore with this whole India approval - over a month gone and we are now being ignored when we ask what has gone wrong - David sounded so confident during the investor meeting that approval was literally around the corner.
It concerns me simply because I need to know I can trust the CEO of any company I'm invested in.
thanks guys. i agree we all need to make a combined effort to get a sensible response from the company. Enough is enough.
thanks. i didnt get any response, not that it answers the question though .....
seriously guys. instead of complaining on here, contact walbrook and find out whats going on with that 'very very close india approval. The company cant get away with going quiet on us again. There is not much that is more important, when investing in AIM, than a CEO you can trust! Sorry but that comment is a real irritant given the months of silence on approvals that came before.
i have queried the whole indian approval "very very close" thing with walbrook but still no response and they arent picking up the phone the past few times ive called. After what has gone on with approvals previously, that comment by Budd needs explaining....its been over a month. i suggest everyone tries to contact walbrook to get Budd to explain whats gone wrong there.
id be concerned if there is no material news by the time bgf have sold out
yes i agree. it hasnt worked out quite as they hoped. they probably hoped news by now wouldve meant a higher sp to sell their second batch of shares at, but hasnt worked that way.
it seems that bgf were targetting selling out end of the calendar year regardless of news.
Still no indian approval news.
They seem to reasonably stick to provided timelines where it comes to product development at least. Expecting news on this shortly though....
The Genedrive SARS-CoV-2 POC Kit follows a similar workflow that has already been validated in the Company's Genedrive® HCV-ID Kit which received WHO pre-qualification earlier this year. The Company is targeting the end of the calendar year for completion of preliminary product evaluations
GW